home / stock / lqda / lqda articles

LQDA Articles, Liquidia Technologies Inc. - From 01/02/24

Stock Information
Company Name: Liquidia Technologies Inc.
Stock Symbol: LQDA
Market: NASDAQ
Website: liquidia.com
Menu
LQDA LQDA Quote LQDA Short LQDA News LQDA Articles LQDA Message Board
Get LQDA Alerts

News, Short Squeeze, Breakout and More Instantly...
Liquidia Corporation to Present at 42nd Annual J.P. Morgan Healthcare Conference | Benzinga

MORRISVILLE, N.C., Jan. 02, 2024 (GLOBE NEWSWIRE) -- Liquidia Corporation (NASDAQ:LQDA) (Liquidia or the Company) announced today that Dr. Roger...
U.S. Federal Circuit Affirms Earlier PTAB Decision to Invalidate All Claims of United Therapeutics Patent No. 10,716,793 ('793 Patent) | Benzinga

Liquidia will pursue final FDA approval for YUTREPIA™ (treprostinil) inhalation Liquidia will immediately request that District Court set ...

Why Is Pulmonary Hypertension-Focused Liquidia Stock Soaring Today? | Benzinga

Liquidia Corp (NASDAQ: LQDA) stock jumped after a win in a patent dispute with United Therapeutics Corporation (NASDAQ: UT...

Why Steelcase Shares Are Trading Lower By Around 13%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session | Benzinga

Steelcase Inc. (NYSE: SCS) shares moved higher during Wednesday's session following quarterly results. Steelcase posted upbeat earnings for its...
Toro Posts Upbeat Results, Joins Clear Channel Outdoor, Marathon Digital And Other Big Stocks Moving Higher On Wednesday | Benzinga

U.S. stocks traded mixed, with the Dow Jones index falling around 50 points on Wednesday. Shares of The Toro Company (NYSE: TTC) rose sharply durin...

Liquidia Announces Pricing of Public Offering of Common Stock | Benzinga

MORRISVILLE, N.C., Dec. 12, 2023 (GLOBE NEWSWIRE) -- Liquidia Corporation (NASDAQ:LQDA) announced today that it has priced an underwritten publi...

Liquidia Corporation to Report Third Quarter 2023 Financial Results on November 7, 2023 | Benzinga

MORRISVILLE, N.C., Oct. 31, 2023 (GLOBE NEWSWIRE) -- Liquidia Corporation (NASDAQ:LQDA) announced today that it will report its third quarter 20...
Emergent BioSolutions Names Two Pharmaceutical Industry Veterans to Board of Directors | Benzinga

GAITHERSBURG, Md., Oct. 02, 2023 (GLOBE NEWSWIRE) -- Emergent BioSolutions Inc. (NYSE:EBS) today announced the appointment of Neal Fowler and Do...

United Therapeutics Corporation Files Lawsuit Alleging Infringement of Tyvaso Patent Already Found to Be Invalid by U.S. Patent Office | Benzinga

Asserts ‘793 patent in new litigation filed under Hatch-Waxman Act in response to Liquidia's amendment to its NDA to add PH-ILD to YUTREPI...

Previous 10 Next 10